Due to the observations that the inhibition of IDO1 activity enhanced the radiosensitivity of cervical CSCs (Figure 2), we hypothesize that the IDO1 inhibitors could function as radiosensitizers for helping the radiation therapy in cervical cancer. The gene discussed is IDO1; the disease is cervical carcinoma.